Transense Technlgy - Trading update and Investor Meet Company seminar

Transense Technologies

Today 07:00

RNS Number : 1802J
  
Transense Technologies PLC
  
22 June 2026
  
 


The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
 
22 June 2026
 
Transense Technologies plc
("Transense" or the "Company")
 
Trading update and Investor Meet Company seminar
 
Transense Technologies plc (AIM: TRT), the provider of specialist sensing solutions and measurement systems, provides an update on trading for the year ending 30 June 2026 ("FY26") and outlook for FY27.
The Company expects to report:
·      Revenue of not less than £4.6m,
·      Adjusted EBITDA of not less than £0.5m,
·      Adjusted profit before tax of approximately break-even.
This represents a modest reduction versus expectations set in January 2026, primarily reflecting:
·      Lower than anticipated sales from global tyre manufacturers within Translogik, offset by good conversion of new business.  Demand from tyre majors expected to recover in FY27,
·      SAWsense development projects progressing well, although customer commitment to short term non-recurring engineering (NRE) costs slightly slower than anticipated,
·      Bridgestone iTrack royalty income as expected.
Cash at 31 May 2026 was £1.12m (31 Dec '25: £1.33m) and net cash of £0.71m (31 Dec '25: £0.92m). Planned working capital movements in June will temporarily reduce this position at the year end, reversing with strong cash collections due in July.
Progress update
·      SAWsense: Continued revenue growth led by T901 and motorsports programmes, with a pipeline of development contracts across other key target markets, especially robotics,  moving towards production. Revenue is expected to be not less than £1.3m (FY25: £1.12m, FY26H1: £0.66m),
·      Translogik: Strengthening pipeline and increasing direct and distribution activity, offsetting reduced demand from global tyre majors. Revenue is expected to be not less than £1.25m (FY25: £1.32m, FY26H1: 0.59m).  Revenue from new product launches expected to come on stream in FY27,
·      Bridgestone iTrack royalty: FY26 royalty income is expected to be not less than £2.0m and outlook for FY27 anticipated to show further modest growth,
·      Commercial pipeline: Several customer and partnership agreements are at an advanced stage at Translogik, with terms substantially agreed and expected to conclude in the near term.  SAWsense continuing to build development pipeline with earliest production dates in 2027/28 continuing to be a realistic goal,
·      Operations: Pilot production line procurement complete, and initial production validation and process control results as expected.




Outlook for FY27
 
The Board remains confident in the Company's medium-term growth opportunities across both business segments. However, consistent with a prudent approach, FY27 expectations are being moderated to reflect:
·      The timing of conversion of advanced commercial opportunities carrying a degree of uncertainty,
·      Both business segments are working towards firm contractual commitments on several significant programmes, but these are not yet formalised.
These opportunities are actively progressing and have the potential to materially enhance performance in FY27 and beyond.  Further announcements are expected as these are completed.
The Board also intends to continue to adopt the current financing strategy, whereby gross cash headroom is targeted to remain at around £1m.  Trading at a profit at Adjusted EBITDA level is planned to provide internal cash generation sufficient to fund movements in working capital and further investment in new products and componentry.
 
Summary
While FY26 performance is slightly below earlier expectations, the underlying business continues to make solid operational progress, with:
·      Growth in core SAWsense activity
·      A strengthening commercial pipeline across both SAWsense and Translogik
·      Multiple near-term contract opportunities
The Board believes the Company remains well positioned for future growth, with further updates to be provided as commercial agreements are secured.
 
Comment
Nigel Rogers, Executive Chairman, said:
"We have continued to build strong momentum both commercially and operationally, particularly in SAWsense, while also advancing a number of significant new opportunities in both business units.
Whilst the timing of contract conversion has impacted short-term expectations, we remain confident in the underlying growth potential of the business and look forward to updating shareholders as these opportunities progress."
 
Investor Meet Company seminar
Nigel Rogers (Executive Chairman) will be available to answer questions on the trading update via Investor Meet Company on Tuesday 23 June at 4:30pm GMT.
The seminar is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard prior to or during the seminar.
Investors can sign up to Investor Meet Company for free and add to meet Transense via:
https://www.investormeetcompany.com/transense-technologies-plc/register-investor
Investors who already follow the Company on the Investor Meet Company platform will automatically be invited.
 
 
 
For further information please visit www.transense.com or contact:
 




Transense Technologies plc
Nigel Rogers (Executive Chairman)
Ryan Maughan (Managing Director)
Melvyn Segal (Chief Financial Officer)


Via Investor Relations
(see below)




Cavendish Capital Market Limited (Nominated Adviser and Broker)
Adrian Hadden / Callum Davidson (Corporate Finance)
Jasper Berry (Sales)








Investor Relations
Anice McNamee


Tel: +44 (0)1869 238380 investor.relations@transense.co.uk




 
 
 
 
Notes to Editors:
Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:
 
·    SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.
 
·    Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.
 
In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.
 
Find out more at: https://www.transense.com/




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
TSTBCGDLRSDDGLB